These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31061510)

  • 1. Bile-duct proliferation as an unexpected side-effect after AAV2-LDLR gene transfer to rabbit liver.
    Hytönen E; Laurema A; Kankkonen H; Miyanohara A; Kärjä V; Hujo M; Laham-Karam N; Ylä-Herttuala S
    Sci Rep; 2019 May; 9(1):6934. PubMed ID: 31061510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.
    Kankkonen HM; Vähäkangas E; Marr RA; Pakkanen T; Laurema A; Leppänen P; Jalkanen J; Verma IM; Ylä-Herttuala S
    Mol Ther; 2004 Apr; 9(4):548-56. PubMed ID: 15093185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
    Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
    J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.
    Chowdhury JR; Grossman M; Gupta S; Chowdhury NR; Baker JR; Wilson JM
    Science; 1991 Dec; 254(5039):1802-5. PubMed ID: 1722351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.
    Wilson JM; Johnston DE; Jefferson DM; Mulligan RC
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4421-5. PubMed ID: 2454468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.
    Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S
    Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.
    Somanathan S; Jacobs F; Wang Q; Hanlon AL; Wilson JM; Rader DJ
    Circ Res; 2014 Aug; 115(6):591-9. PubMed ID: 25023731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model.
    Hou X; Jiao R; Guo X; Wang T; Chen P; Wang D; Chen Y; He CY; Chen ZY
    Gene Ther; 2016 Aug; 23(8-9):657-63. PubMed ID: 27092942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice.
    Ou H; Zhang Q; Zeng J
    J Genet; 2016 Jun; 95(2):311-6. PubMed ID: 27350674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
    Shichiri M; Tanaka A; Hirata Y
    Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice.
    Leggiero E; Labruna G; Iaffaldano L; Lombardo B; Greco A; Fiorenza D; Gramanzini M; Montanaro D; Baldi A; Cerullo V; Sacchetti L; Pastore L
    Gene Ther; 2019 Apr; 26(3-4):121-130. PubMed ID: 30700805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).
    Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.
    Muthuramu I; Amin R; Postnov A; Mishra M; Aboumsallem JP; Dresselaers T; Himmelreich U; Van Veldhoven PP; Gheysens O; Jacobs F; De Geest B
    Mol Ther; 2017 Nov; 25(11):2513-2525. PubMed ID: 28822689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
    Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
    EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.
    Oka K; Mullins CE; Kushwaha RS; Leen AM; Chan L
    Gene Ther; 2015 Jan; 22(1):87-95. PubMed ID: 25231173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for familial hypercholesterolemia.
    Van Craeyveld E; Jacobs F; Gordts SC; De Geest B
    Curr Pharm Des; 2011; 17(24):2575-91. PubMed ID: 21774774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.